Home | Jobs | Contact Us

Online Posttest

Blunting Macrovascular Risk: New Perspectives in Metabolic Interventions

Posttest for Joslin ClinicalFOCUSTM Internet Archive

This online posttest is for participants of the activity titled Blunting Macrovascular Risk: New Perspectives in Metabolic Interventions. In order to receive credit, you should have participated in the activity before taking this posttest. You will need the access code listed in the Method of Participation section of the participant packet to register for the posttest. You should have downloaded this packet when you registered for the Internet archive activity.

If you have not participated in this activity, you can register here.

There is no fee for participation in this activity.

The estimated time for completion of the activity is 60 minutes.

Accreditation and Designation of Credit
The Joslin Diabetes Center, Boston is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Joslin Diabetes Center designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This CME activity was planned and produced in accordance with ACCME Essentials.

CME Release Date: 10/10/2006
CME Expiration Date: 10/10/2007
Computer Requirements
To participate in this posttest activity, your computer will need the following hardware and software:
  • Windows 95, 98, 2000, XP, or NT
  • Internet Explorer 4.01 or higher - download latest version
  • Internet connection, 56Kbps or faster
  • Color monitor, 800 X 600 screen resolution or higher
Questions About This Activity
For questions pertaining to the content of this activity, please contact the Professional Education Department at 888-567-5460.

This activity is supported by an educational grant from King Pharmaceuticals.



This activity is supported by an educational grant from Wyeth Pharmaceuticals.
 
Privacy | Disclaimer | Site Map | Back to Top